Foley catheter plus oxytocin versus oxytocin alone for inducing labor after preterm PROM
Official title: Combination Oxytocin/Foley Versus Oxytocin Alone for Induction of Labor in Patients With Preterm Prelabor Rupture of Membranes
Run by Eastern Virginia Medical School · NCT07119398 · Data updated 2026-11-12
This trial tests whether adding a Foley catheter to oxytocin helps people with preterm PROM (34w0d–36w6d) go into labor and deliver faster than oxytocin alone.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | Eastern Virginia Medical School Academic / other |
| Locations | 1 site (Norfolk, Virginia) |
| Status | Recruiting |
| Started | July 14, 2025 |
| Main results expected | July 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | August 13, 2025 |
| Trial ID | NCT07119398 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People aged 18–50 with PPROM between 34w0d and 36w6d, cervical dilation ≤2 cm, a cephalic fetus, and who can consent and receive care at the study site are ideal candidates.
✕Probably not a fit
Patients already in active labor, with cervical dilation >2 cm, chorioamnionitis, contraindications to a Foley, HIV, known fetal anomalies, or other exclusion criteria are unlikely to be eligible or benefit from this approach.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Patients with preterm prelabor rupture of membranes between 34 0/7 and 36 6/7 weeks, with a cervix ≤2 cm and a fetus in cephalic presentation, are enrolled at a single center. Enrolled participants receive either a Foley catheter plus oxytocin or oxytocin alone for induction and are monitored for labor progress, time to delivery, and maternal and neonatal outcomes. The trial excludes patients in spontaneous labor, with chorioamnionitis, significant cervical dilation, contraindications to a Foley, HIV, or known fetal anomalies. Study procedures and outcomes focus on whether the Foley plus oxytocin approach shortens the time to delivery and affects infection or other complications.
Why it matters
Potential benefit: If successful, adding a Foley catheter could shorten the time from induction to delivery and reduce the risks associated with prolonged membrane rupture.
How similar studies have gone: Previous randomized data show Foley plus oxytocin shortens time to delivery in term pregnancies and oxytocin versus misoprostol showed no clear difference in PPROM, but Foley use has not been prospectively tested in patients with PPROM.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18-50 years of age; * The patient is fluent in English, physically and mentally able to understand the informed consent, and is willing to participate in this study; * PPROM; * Cervical dilation \</= 2cm * Fetal cephalic presentation; * The patient is between 34 weeks 0 days and 36 weeks 6 days of gestation at the time of enrollment. Gestational age will be determined by last menstrual period, confirmed with a first trimester ultrasound, per the recommended guidelines by the American College of Obstetricians and Gynecologists. Exclusion Criteria: * Spontaneous labor * Known allergy to latex; * Cervical dilation \>2cm; * Chorioamnionitis; * Contraindications to induction of labor or use of Foley for cervical ripening * HIV * Known or suspected fetal anomaly or aneuploidy; * Prisoners.
Where it's running
-
Sentara Norfolk General Hospital
Norfolk, Virginia, United States Recruiting
Study contacts
- Principal investigator: Marwan Ma'ayeh, MD — Eastern Virginia Medical School
- Study coordinator: Kristin Ayers, MPH
- Email: ayerskl@evms.edu
- Phone: 7574460529
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using antibiotics to prolong pregnancy after premature rupture of membranes
This study is testing if giving antibiotics to women with a premature rupture of membranes can help them keep their pregnancy going longer.
-
Amniotic Fluid DNA sequencing to detect infection in women with short cervix or PROM
This study tests a nanopore DNA sequencing method on amniotic fluid to see if it more reliably detects infection and inflammation than standard bacterial cultures in pregnant women with short cervix or premature rupture of membranes.
-
Selective antibiotics when symptoms develop versus universal antibiotics for preterm neonates
In preterm babies at risk for sepsis, researchers test whether giving antibiotics only to those who show symptoms is as safe as giving antibiotics to all at-risk babies in the first week of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.